Literature DB >> 8279670

Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome.

R F Butterworth1, J J Kril, C G Harper.   

Abstract

Chronic alcoholism results in thiamine deficiency as a consequence of poor nutrition, impaired absorption, and decreased phosphorylation to the enzyme cofactor form of the vitamin, thiamine pyrophosphate (TPP). Results of this study demonstrate significant reductions of TPP-dependent enzymes [pyruvate dehydrogenase complex, alpha-ketoglutarate dehydrogenase (alpha KGDH), and transketolase] in autopsied cerebellar vermis samples from alcoholic patients with the clinical and neuropathologically confirmed diagnosis of Wernicke-Korsakoff Syndrome (WKS). Enzyme activities in brain samples from alcoholics without WKS were within normal limits and activities of a nonthiamine-dependent enzyme, glutamate dehydrogenase, were not significantly different from control values in brain samples from alcoholics with or without WKS. These findings provide evidence, for the first time, of a direct implication of TPP-related metabolic processes in the pathogenesis of WKS. Decreased activities of alpha KGDH could be the trigger for a sequence of metabolic events resulting in energy compromise, and ultimately neuronal death in this syndrome.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8279670     DOI: 10.1111/j.1530-0277.1993.tb05668.x

Source DB:  PubMed          Journal:  Alcohol Clin Exp Res        ISSN: 0145-6008            Impact factor:   3.455


  46 in total

1.  Effect of alcohol on energy storage of primary astrocytes and C6-glioma cells in vitro.

Authors:  N Haghighat; D W McCandless; P Geraminejad
Journal:  Metab Brain Dis       Date:  1999-09       Impact factor: 3.584

Review 2.  Mitochondrial enzymes and endoplasmic reticulum calcium stores as targets of oxidative stress in neurodegenerative diseases.

Authors:  Gary E Gibson; Hsueh-Meei Huang
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

3.  Double-blind, randomized placebo-controlled clinical trial of benfotiamine for severe alcohol dependence.

Authors:  Ann M Manzardo; Jianghua He; Albert Poje; Elizabeth C Penick; Jan Campbell; Merlin G Butler
Journal:  Drug Alcohol Depend       Date:  2013-08-11       Impact factor: 4.492

Review 4.  The current state of S. S. Korsakov's concept of alcoholic polyneuritic psychosis.

Authors:  Yu P Sivolap
Journal:  Neurosci Behav Physiol       Date:  2005-11

Review 5.  Alpha-ketoglutarate dehydrogenase: a target and generator of oxidative stress.

Authors:  Laszlo Tretter; Vera Adam-Vizi
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2005-12-29       Impact factor: 6.237

Review 6.  Pathophysiology of alcoholic brain damage: synergistic effects of ethanol, thiamine deficiency and alcoholic liver disease.

Authors:  R F Butterworth
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 7.  Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome.

Authors:  P R Martin; B A McCool; C K Singleton
Journal:  Metab Brain Dis       Date:  1995-03       Impact factor: 3.584

Review 8.  Alterations of thiamine phosphorylation and of thiamine-dependent enzymes in Alzheimer's disease.

Authors:  M Héroux; V L Raghavendra Rao; J Lavoie; J S Richardson; R F Butterworth
Journal:  Metab Brain Dis       Date:  1996-03       Impact factor: 3.584

9.  Novel functions of the alpha-ketoglutarate dehydrogenase complex may mediate diverse oxidant-induced changes in mitochondrial enzymes associated with Alzheimer's disease.

Authors:  Qingli Shi; Hui Xu; Wayne A Kleinman; Gary E Gibson
Journal:  Biochim Biophys Acta       Date:  2007-12-31

10.  Induction of nitric oxide synthase and microglial responses precede selective cell death induced by chronic impairment of oxidative metabolism.

Authors:  N Y Calingasan; L C Park; L L Calo; R R Trifiletti; S E Gandy; G E Gibson
Journal:  Am J Pathol       Date:  1998-08       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.